Fibromyalgia developed after administration of gonadotrophin-releasing hormone analogue

Clinical Rheumatology

Volumn 20, Issue 2, 2001, Pages 150-152

  Toussirot, E ^a   Wendling, D ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Fibromyalgia; Gonadotrophin releasing hormone analogues; Hormones

Indexed keywords

AMITRIPTYLINE; ANTIINFLAMMATORY AGENT; DEXTROPROPOXYPHENE; GONADORELIN; LEUPRORELIN; NEUROTRANSMITTER; PARACETAMOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; ENDOMETRIOSIS; FEMALE; FIBROMYALGIA; HUMAN; HYSTERECTOMY; MUSCULOSKELETAL DISEASE; NEUROENDOCRINE DISEASE; NEUROPSYCHOLOGY; NEUROTRANSMITTER RELEASE; OVARIECTOMY; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; SLEEP DISORDER;

EID: 0035043364     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011195     Document Type: Article

References (9)

1. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome
2. Pain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis
3. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee
4. Therapeutic applications of luteinizing-hormone-releasing hormone and its analogs
5. Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles
6. Neurohormonal perturbations in fibromyalgia
7. Severe fibromyalgia after hypophysectomy for Cushing's disease
8. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones
9. Hormonal perturbations in fibromyalgia syndrome